Which medications can induce bradycardia (abnormally slow heart rate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications That Can Induce Bradycardia

Beta-blockers, calcium channel blockers (particularly verapamil and diltiazem), and digoxin are the primary medications that can induce bradycardia, often through their negative chronotropic effects on the heart. 1, 2

Common Medications That Cause Bradycardia

Cardiovascular Medications

  • Beta-blockers (propranolol, metoprolol, carvedilol) - These medications block beta-adrenergic receptors, reducing heart rate and are a major cause of drug-induced bradycardia 3, 4
  • Non-dihydropyridine calcium channel blockers (verapamil, diltiazem) - These agents slow AV nodal conduction and decrease heart rate 5
  • Digoxin - Can cause bradyarrhythmias at therapeutic doses in sensitive individuals or in overdose 2
  • Antiarrhythmic drugs (amiodarone, sotalol, propafenone) - Many have negative chronotropic properties 1, 2
  • Ivabradine - Concurrent use with other negative chronotropic agents like diltiazem can exacerbate bradycardia 5
  • Clonidine - Can cause marked sinus bradycardia 1

Chemotherapeutic Agents

  • Cisplatin, 5-fluorouracil, paclitaxel/docetaxel - These agents have been associated with bradycardia 1, 2
  • Thalidomide and arsenic trioxide - Can induce bradycardia through various mechanisms 2

Other Medications

  • Opioids - Can induce bradycardia through parasympathetic stimulation 6
  • Cholinergic agents - Increase vagal tone, slowing heart rate 2
  • Lithium - Can cause bradyarrhythmias, especially at toxic levels 1
  • Methyldopa - Listed as a cause of bradycardia 1
  • Risperidone - Can induce bradycardia in some patients 1
  • Interferon - Associated with bradycardia 1

Risk Factors for Drug-Induced Bradycardia

  • Advanced age - Elderly patients are more susceptible to drug-induced bradycardia 7, 8
  • Renal or hepatic impairment - Affects drug metabolism and clearance 3, 8
  • Polypharmacy - Especially combinations of negative chronotropic agents 8
  • Pre-existing cardiac disease - Increases susceptibility to bradycardia 6
  • Electrolyte abnormalities - Hypokalemia or hypocalcemia can potentiate bradycardia 2

Dangerous Drug Combinations

  • Beta-blockers + calcium channel blockers - This combination can have synergistic effects on heart rate, causing profound bradycardia 3, 5, 8
  • Beta-blockers + digoxin - Both slow AV conduction and decrease heart rate, increasing risk of bradycardia 3, 4
  • Sodium channel blockers + beta-blockers - Can cause severe bradycardia, even months after starting therapy 7
  • Multiple negative chronotropic agents - The risk increases with each additional agent 8

Clinical Significance and Management

  • Symptoms of clinically significant bradycardia include syncope, dizziness, fatigue, chest pain, and dyspnea 9, 10
  • Acute management of symptomatic bradycardia may include atropine, especially for vagally-mediated bradycardia 1, 9
  • For medication-induced bradycardia, discontinuation of the offending agent is the primary intervention 9, 11
  • In severe cases, temporary pacing may be required until the medication effect resolves 9
  • Prevention strategies include careful medication selection, dose adjustment, and monitoring in high-risk patients 11

Important Caveats

  • Some patients may develop bradycardia even months after starting a medication, particularly with combinations of negative chronotropic agents 7
  • Bradycardia can occur at therapeutic doses in sensitive individuals 2, 8
  • Athletes and young, healthy individuals often have physiologic bradycardia that is not pathological 9, 10
  • Always consider drug-induced causes when evaluating a patient with new-onset bradycardia 11

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Bradycardia Causes and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Opioid-Induced Bradycardia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Profound sinus bradycardia due to diltiazem, verapamil, and/or beta-adrenergic blocking drugs.

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society, 2004

Research

Bradyarrhythmias: clinical significance and management.

Journal of the American College of Cardiology, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.